MARAGANORE JOHN reported 2 transactions at HEMAB THERAPEUTICS HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/4/2026ACC: 0001193125-26-204048
Director
Since Apr 2026
+141.65K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
143.29K acquired · 1.63K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+17.97K
Price / share
—
Trade value
—
% of position
New position
5/4/2026
0.00→17.97K
Common Stock
Direct
Shares
+17.97K
Price / share
—
Trade value
—
% of position
100.0%
5/4/2026
17.97K→35.95K
Total
Net shares
+35.95K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2026 | C · Conversion | +17.97K | — | — | New position | 0.00 | 17.97K |
| Common Stock Direct | 5/4/2026 | C · Conversion | +17.97K | — | — | 100.0% | 17.97K | 35.95K |
| Total | +35.95K | $0.00 | ||||||
Derivative Transactions3
Warrants (Right to Buy)
Direct
Converts to
Common Stock
107.34K shares
Shares
+107.34K
Strike price
6
Held after
107.34K
Exercisable
—
1/29/2026
Series B Preferred Stock
Direct
Converts to
Common Stock
17.97K shares
Shares
−817.00
Strike price
Held after
0.00
Exercisable
—
5/4/2026
Series C Preferred Stock
Direct
Converts to
Common Stock
17.97K shares
Shares
−817.00
Strike price
Held after
0.00
Exercisable
—
5/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants (Right to Buy) Direct | Common Stock107.34K shares | 1/29/2026 | A · Award | +107.34K | 6 | — | 107.34K |
| Series B Preferred Stock Direct | Common Stock17.97K shares | 5/4/2026 | C · Conversion | −817.00 | — | 0.00 | |
| Series C Preferred Stock Direct | Common Stock17.97K shares | 5/4/2026 | C · Conversion | −817.00 | — | 0.00 |